Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Neuroscience Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Stroke Summit 2023

Conference Overview

On behalf of Conference Series, we take immense pleasure in inviting all the participants from all over the world to attend “10th International Conference on Stroke and Neurological Disorders” to be held on October 16-17, 2023 at Vienna, Austria.

Stroke Summit 2023 has been planning and aiming to stimulate new techniques for treatment of stroke and neurological disorders that would be beneficial for the neurosurgery and neuroscience. The conference will be organized around the theme "Shape up a healthier and disorder-free world”. Our goal is to bring together worldwide distinguished academics in the field of Brain and Neurology to exchange and share pleasant experiences of various treatment procedures for Stroke and Neurological disorders.

Scope and Importance:

Most countries in the world now provide access to medical education. Stroke and Neurological disorders conference provides platform to encourage people to take preventive measures and control of their health against the neurological disorders based on a full range of information and access to education in the field of diagnosis, prevention and treatment.

Stroke summit 2023 is intended to honour prestigious award for:

  • Talented Young researchers
  • ScientistsYoung InvestigatorsPost-Graduate studentsPost-doctoral fellows,
  • Trainees, Junior faculty

Stroke summit 2023 helps in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Neurology and Neuroscience.

Young Researchers Awards at Stroke summit 2023 for nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Stroke Summit 2023.

YRF Registration benefits:

  • Young Scientist Award recognition certificate and memento to the winners.
  • Stroke summit 2023 provides best Platform for your research through oral presentations.
  • Learn about career improvement with all the latest technologies by networking.
  • Provide an opportunity for research interaction and established senior investigators across the globe in the field of Neuroscience.
  • It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

 

Why to attend

The goal of the conference is to develop projects in translational neuroscience that will enable people to better understand how the field has developed over the past few years and how treatment methods have advanced.The four typical goals of the conference are patient care, innovation, digital neurology, and research. Innovative technologies are altering our understanding of and approach to treating neurological problems in the rapidly developing fields of neuroscience and neurology.

The theme of Stroke summit 2022 is “Shape up a healthier and disorder-free world” emphasizing the importance of collaboration and communication among individuals from diverse professions.

The congress offers unparalleled networking opportunities, interactive breakout sessions, numerous speakers, and hands-on practise. And an honorarium is merely a waypoint for you to connect in person with local organisations, teams, experts, and exhibitors in order to deepen your knowledge, share ideas, and have a special time in a beautiful setting.

The conference will feature a student poster competition and a young researchers forum to entice undergraduates and recent graduates to submit their unique research, which will thereafter be published in Conference Series Journals. During the conference, poster sessions will be held to display all approved abstracts. All participants who are unable to attend the conference are given the chance to submit electronic posters with an abstract that is published on the website with a DOI number.

Target audience:

  • Doctors, Young Research Scientists, Medical Colleges, Pediatric Cancer Associations and Societies, Manufacturing Medical Devices Companies, Healthcare Professionals, and  Directors of healthcare Companies
  • Neurologists, Neurosurgeons, Rehabilitation specialists, psychiatrists, physiologists, Pharmacists, Research scientists, Neurology Organizations & societies, Pharma (drug design and discovery) companies, Neuro and CNS drug Industries, Neuroscience associations and foundations, Professors and Students from Academia in the study of neurological disorder and Stroke and researchers who utilize neurophysiological techniques and knowledge in the diagnosis and management of patients with disorders of the nervous system.
  • Our Congress imparts new thoughts, beliefs, techniques and strategies that legitimately influence the way we work together. No other conference will offer a great selection of keynote speakers, high-profile attendees, and engaging content.

Stroke summit 2023 highlights:

  • Stroke summit 2023 will bring together the exchange of legitimate thoughts and perspectives from leading researchers, as well as economic pioneers and speculators in this exciting field. Prominent speakers and leading researchers and specialists from around the world are invited to share their knowledge and experiences.
  • Event attendees are typically high-level decision makers representing different parts of the industry, and many of the attendees are our previous speakers who know each other. This creates an informal and casual environment with the right attitudes towards gathering new people.
  • A neurological problem is the confusion occurred in the nervous system; it can also clear up as additional electrical or biochemical abnormalities in the spine, brain or some other nerve. This can also provoke different types of manifestations.

We look forward to welcoming you and inviting you to participate in our exciting conference. Provide us the opportunity to meet and greet you in one of the most beautiful urban communities in the world.

 

Market Analysis

The global stroke management market had revenues of $22,581 million in 2016 and is anticipated to reach $36,756 million by 2023, expanding at a CAGR of 7.1% during the study period (2017-2023).A stroke is a serious medical emergency that happens when the blood supply to the brain is cut off and the brain cells begin to deteriorate. The market is driven by the increase in the incidence and prevalence of chronic diseases.

Additionally, the market is being driven by the ageing population, which is more prone to strokes, as well as patients' rising rates of diabetes and tobacco use. However, it is projected that the market growth will be constrained by the high cost of therapy and government restrictions for the clearance of cutting-edge equipment and medications.Globally increasing cardiovascular disease (CVD) cases are boosting the industry outlook. According to the CDC, 1 in 5 deaths in the U.S. occurred as a result of heart illness in 2020, killing close to 697,000 people.

Meanwhile, according to the WHO, over 31% of fatalities worldwide are believed to be caused by CVDs, which account for around 17.9 million deaths annually. Cardiac conditions raise the risk of stroke and coronary artery disease, which frequently results in fatalities or other health issues that cause impairments. As a result, there is a significant market for efficient stroke management goods and services.

Segment review:

The global market for stroke management is segmented into diagnostics and medicines based on type. The biggest market share was held by diagnostics, which is also predicted to rise at the fastest rate over the projection period.The market is being driven by an increase in the use of diagnostic procedures including CT scans, MRIs, and others for the early diagnosis of strokes. Due to an increase in the occurrence of ischemic stroke and trauma cases, ischemic stroke had the biggest market share by application.

Geographic review:

The global stroke management market is divided into four geographic regions: North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the greatest portion of the 2016 global market, followed by Europe.

In contrast, it is expected that over the analysis period, Asia will experience the quickest rate of regional growth. The prevalence of chronic diseases and stroke is rising, and government spending on R&D and the construction of better healthcare facilities is rising. These are the main drivers that are fueling the expansion of this market.Due to the concentration of major players in emerging markets and advancements in healthcare infrastructure, Asia-Pacific is anticipated to show the greatest development potential.

Death rate in Europe due to Stroke:

The World Health Organization (WHO) data is used to examine mortality trends in Europe for 37 years between 1980 and 2016 for three specific types of cerebrovascular disease: ischemic stroke, haemorrhagic stroke, and sub-arachnoid haemorrhage (SAH), in which bleeding occurs between the brain and surrounding membrane.

Stroke management high cost procedures disrupted stroke management market development:

One of the most common causes of neurological diagnoses and disability in patients is stroke. As a result, it is typically thought to bring about a significant cost burden, which could impair industry statistics.

By the end of 2030, estimates predict that stroke-related healthcare expenses will have surpassed USD 240 billion worldwide. A major constraint on market growth may come from the increased preference for mechanical thrombectomy over medicinal therapy, which necessitates an interventional procedure and significant costs for imaging tests, medical equipment, and angiography suite time.

Reimbursement policies to foster the hospital end-user segment demand:

The stroke management market is divided into ambulatory surgery centres, diagnostic centres, hospitals, and others depending on end-use. In 2022, the hospital sector has a market share of over 39%.

Due to rising hospital admissions, which are in turn driven by increased access to advantageous reimbursement policies for medical operations carried out in hospital settings, the segment is predicted to experience considerable growth.

According to the American Hospital Association, the number of heart attack and stroke patients hospitalised in the United States in 2022 will exceed 33.3 million.

Funding increment from private and public sectors to strengthen APAC stroke management market size:

By 2032, the market share for stroke management in the Asia Pacific region is anticipated to exceed USD 17 billion. Regional market share will be driven by increasing investments made by both public and private entities in programmes intended to raise awareness about cardiovascular diseases.

Segment expansion will also be determined by the expanding efforts made by top regional industry players to increase their market share in developing Asia-Pacific nations.

To change the stroke management market landscape through mergers and acquisitions:

GE Healthcare, Boston Scientific Corporation, Medtronic, Johnson & Johnson, Penumbra, Inc., and other well-known companies are among the top competitors in the stroke management market. To assemble larger product portfolios and production capabilities, many businesses are putting more emphasis on acquisitions and mergers.

For instance, a pioneer in the field of sophisticated medical device design, Integer Holdings Corporation, purchased Oscor, Inc. in December 2021, another leading company in the field. It is anticipated that the agreement will enable Integer to increase its manufacturing capacity while also broadening its selection of cardiovascular and neurostimulation devices.

COVID-19's effects on market trends for stroke management:

The COVID-19 pandemic had a significant effect on the world market; some nations reported a decline in the number of acute stroke patients. As a result of government directives to reduce COVID-19, a significant drop in stroke consultations and rates of reperfusion therapy, notably thrombolysis, was also seen.

The stroke management market research report provides an in-depth analysis of the sector and revenue estimates and forecasts in USD from 2016 to 2027:

Type-wise segmented:

  • Ischemic
  • Haemorrhagic
  • Transient Ischemic Attack (TIA)

 

Product-wise segmented:

  • Diagnostic Devices
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography Scan (CT scan)
    • Electrocardiography
  • Therapeutic Devices
    • Stent retriever
    • Surgical clips
    • Embolic coils

 End-use

  • Hospitals
  • Ambulatory Surgery Centres
  • Diagnostic Centres

 

Above mentioned information provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Others

 

To Collaborate Scientific Professionals around the World

Conference Date October 16-17, 2023

Speaker Opportunity

Supported By

Journal of Neurological Disorders Journal of Brain Disorders & Therapy International Journal of Emergency Mental Health and Human Resilience

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by